Nuvectis Pharma, Inc. SEC filings NVCT
Nuvectis Pharma, Inc. has 275 filings in SEC EDGAR's recent list, going back to Jul 30, 2021. Its latest annual report, Form 10-K, was filed on Feb 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Aug 21, 2026 | — |
| 424B5 | Prospectus supplement | Jun 30, 2026 | — |
| 424B5 | Prospectus supplement | Jun 29, 2026 | — |
| S-3 | Shelf registration | Feb 13, 2026 | — |
| 424B5 | Prospectus supplement | May 9, 2025 | — |
| 424B5 | Prospectus supplement | Feb 6, 2025 | — |
| 424B5 | Prospectus supplement | Feb 4, 2025 | — |
| S-8 | Employee stock plan registration | Jan 3, 2025 | — |
| S-8 | Employee stock plan registration | Aug 9, 2023 | — |
| S-3 | Shelf registration | Mar 17, 2023 | — |
| S-1 | Registration statement | Aug 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 24, 2022 | — |
| 424B4 | Prospectus | Feb 7, 2022 | — |
| S-1MEF | Filing | Feb 4, 2022 | — |
| S-1/A | Amended registration statement | Jan 24, 2022 | — |
| FWP | Free writing prospectus | Jan 18, 2022 | — |
| S-1/A | Amended registration statement | Jan 18, 2022 | — |
| S-1/A | Amended registration statement | Nov 30, 2021 | — |
| FWP | Free writing prospectus | Nov 9, 2021 | — |
| S-1/A | Amended registration statement | Nov 8, 2021 | — |
| FWP | Free writing prospectus | Nov 4, 2021 | — |
| FWP | Free writing prospectus | Nov 2, 2021 | — |
| S-1/A | Amended registration statement | Oct 28, 2021 | — |
| S-1/A | Amended registration statement | Oct 21, 2021 | — |
| S-1 | Registration statement | Oct 6, 2021 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Fort Lee, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1875558
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.